Literature DB >> 23518829

Reactive thrombocytosis accompanying subclinical hypothyroidism due to Hashimoto's thyroiditis.

Cengiz Beyan1, Kürşat Kaptan.   

Abstract

The important thing in a patient in whom platelet values were detected to be greater than normal is whether thrombocytosis is a reactive phenomenon due to a different pathology or due to a clonal hematological pathology. In this case report, reactive thrombocytosis observed in a case with subclinical hypothyroidism due to Hashimoto's thyroiditis is reported; and according to our literature review, this is the first reported case of reactive thrombocytosis due to Hashimoto's thyroiditis and/or subclinical hypothyroidism. A 31-year-old man without any complaint was admitted to the Hematology Department for thrombocytosis which was detected in his routine follow-up. He had been using thyroid hormone replacement for 2 years because of hypothyroidism as Hashimoto's thyroiditis was earlier diagnosed. Due to miscommunication, he stopped his medication levothyroxine 0.1 mg/day 2 weeks in advance and he was still off-drug on admission. Platelet count was 715×10/l in the first admission center. Subclinical hypothyroidism diagnosis was made with the present findings and thyroid hormone replacement therapy was again commenced gradually. Platelet counts and thyroid-stimulating hormone value were normal 6 weeks later. As a result, before making diagnosis of thrombocytosis related to myeloproliferative disease or myelodysplastic syndromes, secondary causes should be investigated carefully.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23518829     DOI: 10.1097/MBC.0b013e32836069f5

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  Clinical association between thyroid disease and immune thrombocytopenia.

Authors:  Shoko Ito; Shin-Ichiro Fujiwara; Rui Murahashi; Hirotomo Nakashima; Sae Matsuoka; Takashi Ikeda; Shin-Ichiro Kawaguchi; Yumiko Toda; Tetsuaki Ban; Takashi Nagayama; Kento Umino; Daisuke Minakata; Kaoru Morita; Hirofumi Nakano; Ryoko Yamasaki; Masahiro Ashizawa; Chihiro Yamamoto; Kaoru Hatano; Kazuya Sato; Iekuni Oh; Ken Ohmine; Yoshinobu Kanda
Journal:  Ann Hematol       Date:  2020-11-09       Impact factor: 3.673

2.  Why cachexia kills: examining the causality of poor outcomes in wasting conditions.

Authors:  Kamyar Kalantar-Zadeh; Connie Rhee; John J Sim; Peter Stenvinkel; Stefan D Anker; Csaba P Kovesdy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-06-08       Impact factor: 12.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.